Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2025-12-27 @ 11:13 PM
Study NCT ID:
NCT04209634
Status:
COMPLETED
Last Update Posted:
2025-08-29
First Post:
2019-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open-Label Efficacy and Safety Study of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy (CHAPLE Disease)
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-27
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-02
Completion Date Type:
ACTUAL
First Submit Date:
2019-12-20
First Submit QC Date:
None
Study First Post Date:
2019-12-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-09-15
Results First Submit QC Date:
None
Results First Post Date:
2023-10-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2023-10-30
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-08-27
Last Update Post Date:
2025-08-29
Last Update Post Date Type:
ESTIMATED